Lapatinib
PRODUCT DETAILS
Brand Name : Lanib
Composition : Lapatinib
Strength availability : 250mg
Manufactured by : BDR
Pack : 120 tablets
Description
Lanib tablets are classified as anti-cancer agent, which is orally active drug used for treating breast cancer.
Chemically classified as quinazoline with strong anti-cancer effect and the tablet Lanib is a synthetic oral tablet
Normally targeted therapy or tyrosine kinase inhibitor drugs are capable of increasing the plasma amino transferase levels which may leads to liver injury.
Lanib tablets are classified as;
1. Tyrosine kinase prohibitor
2. Stop the HER2/neu& epidermal growth factor receptor activity
3. Targeted therapy
4. Signal transduction prohibitor.
INDICATION
Primarily Lanib indicated for advanced breast cancer. Lanib is indicated for the combination with Capecitabine tablets are normally indicated for the treatment of metastatic breast cancer patients in whose cancer cells expressed with EGFR 2 (HER2) and already patients may get an anthracycline, Trastuzumab.
Side Effects:
Rash
Nausea
Dry skin
Hair loss
Vomiting
Mouth sores

Comments
Post a Comment